Notice of Registration - 2013
[Federal Register Volume 78, Number 49 (Wednesday, March 13, 2013)]
[Notices]
[Page 15975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05799]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration;
Johnson Matthey, Inc., Pharmaceuticals Materials
By Notice dated November 1, 2012, and published in the Federal
Register on November 9, 2012, 77 FR 67397, Johnson Matthey, Inc.,
Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania
19428, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Oxycodone (9143) |
II |
| Diphenoxylate (9170) |
II |
| Hydrocodone (9193) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
The company plans to manufacture the listed controlled substances
in bulk for distribution and sale to its customers.
The Thebaine (9333) will also be used to manufacture other
controlled substances for sale in bulk to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Johnson Matthey Inc., Pharmaceuticals Materials to manufacture the
listed basic classes of controlled substances is consistent with the
public interest at this time. DEA has investigated Johnson Matthey
Inc., Pharmaceuticals Materials to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: February 27, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-05799 Filed 3-12-13; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
